About

After a successful tenure as the legal affairs supervisor at Huada Science & Technology Co., Xu Qian joined BGI Genomics, one of the world’s premier genome sequencing centres, in 2013 as general director of the legal affairs department. As part of her role, she is responsible for managing the company’s global legal affairs and risk management with regard to BGI’s domestic and overseas projects. In 2015, Xu was commended for her role in raising RMB 2bn in funds for BGI’s pre-IPO share reform. In recognition of her industry award winning activities, BGI Genomics entrusted her with further responsibility by appointing her secretary of the board later that year. With BGI Genomics starting its major expansion into North America in 2016, Xu was involved in activities related to the opening of its new overseas office in Seattle and will likely be at the forefront of the company’s business development and strategic decision-making. Highly regarded in China’s in-house legal community for her work, in 2016 Xu delivered a keynote speech on “Legal Risks and Countermeasures for Overseas Development of Enterprises” at a forum attended by senior industry peers.